A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Clinical trial NCT07105111 · RECRUITING

Trial details

NCT number: NCT07105111
Sponsor: Neurocrine Biosciences
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Schizophrenia Schizoaffective Disorder Bipolar Disorder Major Depressive Disorder Tardive Dyskinesia

Start date: 2025-08-29
Primary completion: 2027-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.